WEDNESDAY, May 15, 2024 (HealthDay News) — A competitive game with a potential cash reward appeared to help overweight British men lose weight, researchers report. The incentive was winning the “Game of Stones” — a stone is a British measurement of body weight equal to 14 pounds — and pocketingContinue Reading
TUESDAY, May 14, 2024 (HealthDay News) — Semaglutide — the active ingredient in the blockbuster weight-loss drugs Ozempic and Wegovy — can produce long-term weight and heart health benefits, a pair of new studies show. Researchers found that overweight and obese adults lost an average 10% of their body weightContinue Reading
TUESDAY, May 14, 2024 (HealthDay News) — Women who smoke during pregnancy run a higher risk of their kids becoming overweight or obese, and researchers now think they know one reason why. Children born of moms who smoked while expecting tend to have gut bacteria that is significantly different fromContinue Reading
MONDAY, May 13, 2024 (HealthDay News) — People with heart failure are often prescribed what are known as loop diuretic medications to help reduce the fluid buildup that’s a hallmark of the disease. Now, research suggests that taking the blockbuster weight loss drug Wegovy (semaglutide) can help patients reduce theirContinue Reading
MONDAY, May 13, 2024 (HealthDay News) — “Skinny” fat cells might actually make it harder to lose weight and easier to pack on extra pounds, a new study says. Researchers say it’s possible to predict if someone’s going to gain weight based solely on the size of their fat cells.Continue Reading
FRIDAY, May 10, 2024 (HealthDay News) — About 1 in 8 U.S. adults (12%) have tried a weight-loss drug like Wegovy, Ozempic, Zepbound or Mounjaro, a new KFF Health Tracking Poll says. About 6% are taking one right now, the poll found. Most patients say they use the drugs (61%)Continue Reading
THURSDAY, May 9, 2024 (HealthDay News) — Colon cancer steadily increased among young people in the United States over the past two decades, with tweens enduring the most dramatic leap in cancer rates, a new study says. The rate of colon cancer grew 500% among kids 10 to 14 betweenContinue Reading
THURSDAY, May 9, 2024 (HealthDay News) — An experimental procedure could reduce levels of a hunger-triggering hormone by burning part of a person’s stomach lining, a new study reports. In the procedure, doctors snake a tube down the patient’s throat with a tiny device that singes the lining of theContinue Reading
WEDNESDAY, May 8, 2024 (HealthDay News) — Nine of 10 American adults are in the early, middle or late stages of a syndrome that leads to heart disease, a new report finds, and almost 10% have the disease already. “Poor cardiovascular, kidney, and metabolic health is widespread among the U.S.Continue Reading
THURSDAY, April 25, 2024 (HealthDay News) — School lunches will soon contain less added sugars and salt under new nutrition standards announced by the U.S. Department of Agriculture on Wednesday. “We all share the goal of helping children reach their full potential,” Agriculture Secretary Tom Vilsack said in a newsContinue Reading
WEDNESDAY, April 24, 2024 (HealthDay News) — A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF analysis says. That’s because the U.S. Food and Drug Administration has approved the use of Wegovy (semaglutide) to reduce the risk of heartContinue Reading
FRIDAY, April 19, 2024 (HealthDay News) — A head-to-head trial of obese, pre-diabetic people who ate the same amount of daily calories — with one group following a fasting schedule and the other eating freely — found no difference in weight loss or other health indicators. So, despite the factContinue Reading
WEDNESDAY, April 17, 2024 (HealthDay News) — Zepbound, one of the wildly popular weight-loss drugs that millions of Americans now take, eased sleep apnea in obese adults in two company trials, drug maker Eli Lilly announced Wednesday. First approved to treat obesity by the U.S. Food and Drug Administration lastContinue Reading
WEDNESDAY, April 10, 2024 (HealthDay News) — Wegovy, Ozempic and other drugs known as GLP-1 analogues have become wildly popular for controlling diabetes and helping folks lose weight. There were concerns that longer term use of the drugs might raise users’ odds for thyroid cancer, but a Swedish study ofContinue Reading